Sana Biotechnology
Jump to navigation
Jump to search
| Private | |
| Industry | Biotechnology |
| Founder | Steve Harr |
| Headquarters | Seattle, WA, Cambridge, MA |
| Services | Gene therapies |
| Website | sana |
Sana Biotechnology is an biotechnology company creating and delivering in vivo and ex vivo cell therapies and gene therapies. The company is making capabilities around making cells at scale ex vivo, in vivo delivery, hide allogeneic cells, controllable gene and protein expression systems, manufacturing, and research and development.[1][2]
References
- ↑ "Giving highly funded but secretive Moderna a run for its money, Juno-lite Sana raises $700M". FierceBiotech. Retrieved 2020-06-30.
- ↑ "Giving highly funded but secretive Moderna a run for its money, Juno-lite Sana raises $700M". FierceBiotech. Retrieved 2020-06-30.
External links
- Sana Biotechnology linkedin page
- Sana Biotechnology | Crunchbase
- Sana Biotechnology Launches Focusing on Engineering Cells
- Sana Biotechnology Inc - Company Profile and News on bloomberg
- Sana Biotechnology - The Pharma Letter
- Startup Sana Biotechnology Licenses Cell Technology From Harvard University
- Sana Biotechnology Snags $700 Million in Initial Financing Round
- Sana Biotechnology Inc. - Company Profile - BCIQ
- Sana Biotechnology Announces Completion Of Initial Financing
- Jobs at Sana Biotechnology - Greenhouse
- Sana Biotechnology | Biotech Careers
- Sana Biotechnology | FierceBiotech
This article "Sana Biotechnology" is from Wikipedia. The list of its authors can be seen in its historical. Articles taken from Draft Namespace on Wikipedia could be accessed on Wikipedia's Draft Namespace.